Improved in vitro method for screening organophosphate-induced delayed polyneuropathy
Summary
A new cell ELISA method effectively screens organophosphate-induced delayed polyneuropathy (OPIDP) compounds. This in vitro test optimizes routine laboratory analysis, offering a simpler alternative to existing in vivo and morphometric methods.
Area of Science:
- Neurotoxicology
- Cell Biology
- Biochemistry
Background:
- Organophosphate-induced delayed polyneuropathy (OPIDP) is typically assessed using in vivo chicken models and neuronal tissue analysis.
- Existing in vitro methods, while validated, require morphometric analysis for neurite-like sprout growth detection.
Purpose of the Study:
- To optimize an in vitro method for routine laboratory screening of organophosphates.
- To validate a cell ELISA technique for assessing OPIDP-inducing compounds.
Main Methods:
- Utilized permanent neuronal cell lines for in vitro testing.
- Employed cell ELISA to determine cytoskeletal elements.
- Tested seven OPIDP-inducing compounds and nine negative control substances.
Main Results:
- The cell ELISA method demonstrated consistent effects with the original test method for both OPIDP-inducing and control substances.
- Seven known OPIDP-inducing compounds showed characteristic effects.
- Nine negative control substances did not induce OPIDP-related effects.
Conclusions:
- The cell ELISA technique provides a validated and optimized in vitro alternative for screening OPIDP-inducing organophosphates.
- This method is significantly easier to perform than the morphometric approach.
- The findings support the use of cell ELISA for routine laboratory screening of neurotoxic organophosphates.
